1,3-Thiazin-4-one
US4352929A · kind A · utility
2Cited by
6References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 29, 1981 |
| Grant date | Oct 5, 1982 |
| Priority date | — |
| Expiry date | May 29, 2001 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D279/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel cyclized .omega.-carboxyethyl mono- or dithiocarbanilic acids are disclosed as immunoregulatory agents, useful in the treatment of organ transplant reject phenomenon and autoimmune diseases particularly where a delayed hypersensitivity component has been established, such as multiple sclerosis. Additionally described is the use of certain cyclized .omega.-carboxyalkyl mono- or dithiocarbamic acids and certain cyclized .omega.-carboxyalkyl mono- or dithiocarbamic acids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.